Palbocent 125 mg (Palbociclib) is a CDK4/6 inhibitor used for hormone receptor-positive, HER2-negative advanced breast cancer. It slows cancer cell division. Common side effects include neutropenia, fatigue, infections, and nausea. Regular blood monitoring is required during treatment. https://oncologymedi.com/product/palbocent-125-mg-palbociclib/